On ECHEMI
Home > Drugs > Febuxostat Registered Holders
Febuxostat structure

Febuxostat structure

Febuxostat

Crystalline SolidFebuxostat, a selective xanthine oxidase inhibitor, was launched for the chronic management of hyperuricemia in patients with gout. Hyperuricemia is defined as a serum uric acid concentration exceeding the limit of solubility. It predisposes affected persons to gout, a disease characterized by the formation of crystals of monosodium urate or uric acid from supersaturated fluids in joints and other tissues. Crystal deposition is asymptomatic, but it is revealed by bouts of

Find 70 Related Holders

METROCHEM API PRIVATE LTD
United States United States

API Registration Country

API Active
DASAMI LAB PRIVATE LTD
United States United States

API Registration Country

API Active
HEC PHARM CO LTD
United States United States

API Registration Country

API Active
MSN ORGANICS PRIVATE LTD
United States United States

API Registration Country

API Active
INDOCO REMEDIES LTD
United States United States

API Registration Country

API Active
EMCURE PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
JUBILANT BIOSYS LTD
United States United States

API Registration Country

API Active
MATRIX PHARMACORP PRIVATE LTD
United States United States

API Registration Country

API Active
ALEMBIC PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Febuxostat
View 218 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.